Clinical Trial Update: A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease [Phase 1]

View source ↗

Summary

Phase 1 study of PALI-2108 in healthy volunteers and patients with ulcerative colitis or fibrostenosing Crohn's disease is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• PALI-2108

Snippet

Sponsor: Palisade Bio | Conditions: Fibrostenotic Crohn's Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING